


531 F.3d 1372
United States Court of Appeals,
Federal Circuit.
ROCHE PALO ALTO LLC (formerly known as Syntex (U.S.A.) LLC) and Allergan, Inc., Plaintiffs-Appellees,
v.
APOTEX, INC. and Apotex Corp., Defendants-Appellants.
No. 2008-1021.
|
July 9, 2008.
|
Rehearing and Rehearing En Banc Denied Sept. 5, 2008.
Synopsis
Background: Owner of patent for anti-inflammatory eye drops brought action against proposed manufacturer of generic version alleging infringement. The United States District Court for the Northern District of California, Martin J. Jenkins, J., 526 F.Supp.2d 985, granted summary judgment in favor of patent owner. Proposed manufacturer appealed.
 
Holdings: The Court of Appeals, Prost, Circuit Judge, held that:
 
manufacturer failed to establish prima-facie case of non-infringement under the reverse doctrine of equivalents, and
 
manufacturer's validity challenges were barred under doctrine of claim preclusion.
 
Affirmed.
 
